Repair of bone tissue affected by osteoporosis with hydroxyapatite-poly-L-lactide (HAp-PLLA) with and without blood plasma

J Biomater Appl. 2005 Oct;20(2):179-90. doi: 10.1177/0885328205050519.

Abstract

The aim of this study is to examine the reparatory ability of the synthetic biomaterial hydroxyapatite-poly-L-lactide (HAp-PLLA), the replacement of alveolar ridge, and rehabilitation of bone defects caused by osteoporosis, in an experimental group of animals. The experiments are performed on syngeneic Sprague Dawley rats. Osteoporosis is induced by glucocorticoids in rats during a 12-week period. After this, the experimental group of animals is divided into five subgroups. An artificial defect is made in the alveolar bone on the left side of the mandible. In one group of animals, the defect is left to heal by itself, while in other groups, pure HAp-PLLA or one mixed with plasma is implanted. The best results are achieved by the implantation of the HAp-PLLA composite biomaterial mixed with autologous plasma. Formation of a new mandibular bone is seen, growing intensely, leading to rapid osteogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Regeneration*
  • Bone Substitutes / therapeutic use*
  • Durapatite / therapeutic use*
  • Female
  • Implants, Experimental
  • Mandible / pathology
  • Osteoporosis / chemically induced
  • Osteoporosis / pathology
  • Osteoporosis / therapy*
  • Plasma*
  • Polyesters / therapeutic use*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Bone Substitutes
  • Polyesters
  • hydroxyapatite-polylactide
  • Durapatite